Moderna’s mRNA-1647 Vaccine Shows Promise in Fight Against CMV Virus

Moderna’s mRNA-1647 vaccine shows promise in fighting the CMV virus, offering hope to pregnant women. The vaccine’s safety and efficacy have been confirmed in initial and subsequent research phases, with the final phase expected to conclude within months. Professor Tal Biron-Shental emphasizes the significant harm CMV infection can cause to the fetus and the importance of prevention through vaccination.